Renal/Urology · PANCE / PANRE

Urolithiasis (Kidney Stones)

Renal/ureteral calculi causing acute flank pain; calcium oxalate most common.

Also known as: urolithiasis, kidney stones, nephrolithiasis, ureterolithiasis, renal colic

Overview

Formation of crystalline aggregates (calculi) within the urinary tract — kidneys, ureters, bladder, or urethra. Acute presentations are dominated by ureteral stones causing renal colic, with calcium oxalate stones accounting for ~75% of all calculi.

Epidemiology

Lifetime prevalence ~10% in men, ~7% in women. Peak incidence ages 20-50. Recurrence ~50% within 10 years without prevention. Rising in women and adolescents over recent decades.

🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Urolithiasis (Kidney Stones) outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Low fluid intake, concentrated urine
  • Diet: high sodium, high animal protein, low calcium intake (paradoxically increases oxalate absorption), high oxalate (spinach, nuts, tea)
  • Metabolic: hypercalciuria, hyperoxaluria, hyperuricosuria, hypocitraturia, cystinuria
  • Hyperparathyroidism, distal RTA (type 1) — calcium phosphate stones
  • Gout — uric acid stones
  • Recurrent UTIs with urease-producing organisms (Proteus, Klebsiella) — struvite stones
  • Crohn disease, malabsorption, bariatric surgery (enteric hyperoxaluria)
  • Family history, obesity, diabetes, hot climate

Pathophysiology

Stone formation requires urinary supersaturation of stone-forming salts (calcium, oxalate, uric acid) plus inadequate inhibitors (citrate, magnesium). Crystal nucleation occurs on tubular cells (Randall plaques) or in tubular lumens. Growing stones obstruct the ureter, causing distention, prostaglandin release, smooth muscle spasm, and pain referred along splanchnic nerves (T11-L1).

Clinical presentation

Symptoms

  • Sudden severe colicky flank pain radiating to groin/testicle/labia
  • Patient writhing, unable to find comfortable position (contrast with peritonitis where patients lie still)
  • Nausea and vomiting
  • Dysuria, urinary frequency/urgency if stone in distal ureter near bladder
  • Gross hematuria in 30-40%, microscopic in ~85%

Signs / physical exam

  • CVA tenderness (often mild despite severe pain)
  • Patient appears restless and uncomfortable
  • Vital signs may show mild tachycardia, hypertension from pain
  • Fever raises concern for obstructed infected system (urologic emergency)

Classic findings

Writhing patient with acute severe flank pain radiating to groin + hematuria = textbook ureteral stone.

Differential diagnosis

  • Pyelonephritis — Fever, chills, costovertebral angle tenderness, pyuria with bacteriuria, positive culture
  • Ruptured abdominal aortic aneurysm — Older patients, hypotension, pulsatile mass; consider in older patients with first-ever 'stone' pain
  • Ovarian torsion / ectopic pregnancy — Women of reproductive age; pelvic exam, beta-hCG, transvaginal US
  • Appendicitis — Right-sided pain migrating to RLQ, fever, leukocytosis, may mimic right ureteral stone
  • Renal infarction — Risk factors for embolism (Afib, endocarditis); elevated LDH; CT with contrast diagnostic
  • Musculoskeletal pain — Reproducible with palpation, recent trauma or activity, normal UA

Diagnostic workup

Diagnostic criteria

CT-confirmed urinary tract calculus with consistent clinical presentation. Size and location predict spontaneous passage: <5 mm pass ~80%, 5-10 mm ~50%, >10 mm rarely; distal ureteral stones pass more often than proximal.

Labs

  • Urinalysis with microscopy — hematuria (gross or microscopic), pH (acidic favors uric acid; alkaline favors struvite, calcium phosphate), crystals
  • Urine culture if pyuria or fever
  • BMP — Ca, creatinine, electrolytes
  • CBC — leukocytosis suggests infection
  • Beta-hCG in women of reproductive age (before imaging)
  • Stone analysis when stone retrieved
  • Metabolic workup (24-h urine for Ca, oxalate, citrate, uric acid, Na, volume) for recurrent stones, single kidney, or first stone in child

Imaging

  • Non-contrast CT abdomen/pelvis (low-dose) — gold standard; identifies stones >1 mm, hydronephrosis, alternative diagnoses
  • Renal ultrasound — first-line in pregnancy and children; reasonable initial test in adults to detect hydronephrosis (lower sensitivity for small ureteral stones)
  • KUB plain film — limited; misses radiolucent uric acid stones
  • MR urography — alternative in pregnancy when US insufficient

Diagnostic algorithm

Stone TypePrevalenceUrine pHCrystalsPrevention
Calcium oxalate~75%VariableEnvelope/dumbbell-shapedHydration, thiazide, citrate, normal Ca diet
Calcium phosphate~10%Alkaline (>6.5)Amorphous, wedge-shapedTreat distal RTA, hyperparathyroidism
Uric acid~10%Acidic (<5.5)Rhomboid/needle (radiolucent)Alkalinize urine (K-citrate), allopurinol
Struvite (Mg-NH4-PO4)~5-10%Alkaline (>7)Coffin-lidTreat UTI, complete surgical removal
Cystine<1%AcidicHexagonalHydration, alkalinize, tiopronin/penicillamine
Kidney stone types with characteristic urine pH, crystal morphology, and prevention strategies.

Treatment

First-line

  • Pain control — NSAIDs (ketorolac IV/IM, ibuprofen) are first-line; superior to opioids and reduce ureteral spasm; AVOID in CKD, dehydration, or single kidney
  • Opioids (morphine, hydromorphone) as second-line or adjunctive analgesia
  • Antiemetics (ondansetron, metoclopramide)
  • IV fluids only if dehydrated — aggressive forced diuresis does not promote passage
  • Medical expulsive therapy (MET): alpha-blocker — tamsulosin 0.4 mg daily — for ureteral stones 5-10 mm; modest benefit

Second-line / adjunct

  • Urgent urologic intervention (within 24-48 h) if: obstructed infected system (urosepsis), single kidney with obstruction, refractory pain/vomiting, AKI from obstruction
  • Percutaneous nephrostomy or ureteral stent for emergent decompression
  • Definitive treatment options: shock wave lithotripsy (SWL) for stones <2 cm, ureteroscopy with laser lithotripsy (preferred for distal/large stones), percutaneous nephrolithotomy (PCNL) for staghorn or >2 cm renal stones
  • Prevention strategies based on stone type:
  • Calcium stones: high fluid intake (>2.5 L/day urine output), normal dietary calcium, low sodium, low animal protein, thiazide (HCTZ, chlorthalidone, indapamide) for hypercalciuria, potassium citrate for hypocitraturia
  • Uric acid stones: alkalinize urine (potassium citrate to pH 6.5-7), allopurinol if hyperuricosuria
  • Cystine stones: aggressive hydration, alkalinization, tiopronin or D-penicillamine for refractory
  • Struvite stones: complete stone removal + treat infection (urease inhibitor acetohydroxamic acid in select cases)

Complications

  • Urosepsis (obstructed infected system) — urologic emergency requiring decompression
  • Acute kidney injury from obstruction
  • Chronic kidney disease from recurrent stones
  • Recurrent stones (50% recurrence within 10 years)
  • Ureteral stricture from prolonged impaction
  • Hydronephrosis with renal damage if obstruction prolonged

PANCE pearls

  • FEVER + obstructing stone = urologic emergency. Drain immediately (stent or nephrostomy); definitive stone treatment later.
  • Acetazolamide, indinavir, sulfonamides, ceftriaxone, atazanavir can form medication-induced stones.
  • Calcium intake should NOT be restricted in calcium oxalate stones — low dietary calcium increases oxalate absorption and worsens stone formation.
  • Uric acid stones are radiolucent (don't appear on KUB) but visible on CT. Treat by alkalinizing urine — they can dissolve completely.
  • Struvite stones grow rapidly into staghorn calculi; require complete surgical removal — antibiotics alone are insufficient.
  • First stone in a young child or middle-aged adult with single kidney warrants full metabolic workup (24-h urine collections × 2).

References

  • AUA 2016 — Surgical Management of Stones: AUA/Endourological Society Guideline (Assimos et al., J Urol 2016)
  • AUA 2014 — Medical Management of Kidney Stones: AUA Guideline (Pearle et al., J Urol 2014)
  • EAU 2023 — European Association of Urology Guidelines on Urolithiasis 2023

Practice Renal/Urology questions on FirstPassPA

Turn this outline into retention. 3,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Start studying free → Browse all 514 diagnoses

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.